ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts

1 Small-Cap Stock for Long-Term Investors and 2 We Ignore

ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares

After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares.

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting

Data on an eye implant for chronic eye inflammation will be presented in a late-breaking talk Oct. 9.

Understanding Momentum Shifts in (ANIP)

3 Profitable Stocks Worth Investigating

Implied Volatility Surging for ANI Pharmaceuticals Stock Options

ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build

Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension

Oppenheimer Initiates Coverage On ANI Pharmaceuticals with Perform Rating, Announces Price Target of $85

ANI Pharmaceuticals Receives Final FDA Approval Of Its Abbreviated New Drug Application For Everolimus Tablets For Oral Suspension

2 Cash-Producing Stocks to Target This Week and 1 We Avoid